Log in to save to my catalogue

Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human ost...

Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human ost...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dc482f0daa9e4d3e85008a185369ae60

Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation

About this item

Full title

Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-12, Vol.13 (1), p.23013-23013, Article 23013

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Osseointegration is vital to success in orthopedic and dental reconstructions with implanted materials. The bone matrix or cells—particularly osteoblasts—are required to achieve functional contact on the implant surface. Osteoblast induction is therefore essential for osteogenesis to occur. Enhancement of osteoblast adhesion, proliferation, and dif...

Alternative Titles

Full title

Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dc482f0daa9e4d3e85008a185369ae60

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dc482f0daa9e4d3e85008a185369ae60

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-50565-8

How to access this item